#BEGIN_DRUGCARD DB02655

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
1783-96-6

# ChEBI_ID:
17364

# Chemical_Formula:
C4H7NO4

# Chemical_IUPAC_Name:
(2R)-2-aminobutanedioic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
The D-isomer of aspartic acid. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
D-Aspartic Acid

# HET_ID:
DAS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m1/s1

# InChI_Key:
InChIKey=CKLJMWTZIZZHCS-UWTATZPHSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00402

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2655

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
133.1027

# Molecular_Weight_Mono:
133.037507717

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KS7

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-3.5

# Predicted_LogS:
0.03

# Predicted_Water_Solubility:
1.42e+02 g/l

# Primary_Accession_No:
DB02655

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
Not Available

# PubChem_Substance_ID:
Not Available

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01114

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@H](CC(O)=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:21 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Secreted protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
M34237

# Drug_Target_1_GenBank_ID_Protein:
143254

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
nprS

# Drug_Target_1_Gene_Sequence:
>1656 bp
ATGAAAAGGAAAATGAAAATGAAATTAGTACGTTTTGGTCTTGCAGCAGGACTAGCGGCC
CAAGTATTTTTTTTACCTTACAATGCGCTGGCTTCAACGGAACACGTTACATGGAACCAA
CAATTTCAAACCCCTCAATTCATCTCCGGTGATCTGCTGAAAGTGAATGGCACATCCCCA
GAAGAACTCGTCTATCAATATGTTGAAAAAAACGAAAACAAGTTTAAATTTCATGAAAAC
GCTAAGGATACTCTACAATTGAAAGAAAAGAAAAATGATAACCTTGGTTTTACGTTTATG
CGCTTCCAACAAACGTATAAAGGGATTCCTGTGTTTGGAGCAGTAGTAACTGCGCACGTG
AAAGATGGCACGCTGACGGCGCTATCAGGGACACTGATTCCGAATTTGGACACGAAAGGA
TCCTTAAAAAGCGGGAAGAAATTGAGTGAGAAACAAGCGCGTGACATTGCTGAAAAAGAT
TTAGTGGCAAATGTAACAAAGGAAGTACCGGAATATGAACAGGGAAAAGACACCGAGTTT
GTTGTTTATGTCAATGGGGACGAGGCTTCTTTAGCGTACGTTGTCAATTTAAACTTTTTA
ACTCCTGAACCAGGAAACTGGCTGTATATCATTGATGCCGTAGACGGAAAAATTTTAAAT
AAATTTAACCAACTTGACGCCGCAAAACCAGGTGATGTGAAGTCGATAACAGGAACATCA
ACTGTCGGAGTGGGAAGAGGAGTACTTGGTGATCAAAAAAATATTAATACAACCTACTCT
ACGTACTACTATTTACAAGATAATACGCGTGGAAATGGGATTTTCACGTATGATGCGAAA
TACCGTACGACATTGCCGGGAAGCTTATGGGCAGATGCAGATAACCAATTTTTTGCGAGC
TATGATGCTCCAGCGGTTGATGCTCATTATTACGCTGGTGTGACATATGACTACTATAAA
AATGTTCATAACCGTCTCAGTTACGACGGAAATAATGCAGCTATTAGATCATCCGTTCAT
TATAGCCAAGGCTATAATAACGCATTTTGGAACGGTTCGCAAATGGTGTATGGCGATGGT
GATGGTCAAACATTTATTCCACTTTCTGGTGGTATTGATGTGGTCGCACATGAGTTAACG
CATGCGGTAACCGATTATACAGCCGGACTCATTTATCAAAACGAATCTGGTGCAATTAAT
GAGGCAATATCTGATATTTTTGGAACGTTAGTCGAATTTTACGCTAACAAAAATCCAGAT
TGGGAAATTGGAGAGGATGTGTATACACCTGGTATTTCAGGGGATTCGCTCCGTTCGATG
TCCGATCCGGCAAAGTATGGTGATCCAGATCACTATTCAAAGCGCTATACAGGCACGCAA
GATAATGGCGGGGTTCATATCAATAGCGGAATTATCAACAAAGCCGCTTATTTGATTAGC
CAAGGCGGTACGCATTACGGTGTGAGTGTTGTCGGAATCGGACGCGATAAATTGGGGAAA
ATTTTCTATCGTGCATTAACGCAATATTTAACACCAACGTCCAACTTTAGCCAACTTCGT
GCTGCCGCTGTTCAATCAGCCACTGACTTGTACGGTTCGACAAGCCAGGAAGTCGCTTCT
GTGAAGCAGGCCTTTGATGCGGTAGGGGTGAAATAA

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
2203733	Nishiya Y, Imanaka T: Cloning and nucleotide sequences of the Bacillus stearothermophilus neutral protease gene and its transcriptional activator gene. J Bacteriol. 1990 Sep;172(9):4861-9.
3149972	Kubo M, Imanaka T: Cloning and nucleotide sequence of the highly thermostable neutral protease gene from Bacillus stearothermophilus. J Gen Microbiol. 1988 Jul;134(7):1883-92.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2457

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
60617

# Drug_Target_1_Name:
Bacillolysin

# Drug_Target_1_Number_of_Residues:
551

# Drug_Target_1_PDB_ID:
1KTO

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01447	Peptidase_M4
PF02868	Peptidase_M4_C
PF03413	PepSY
PF07504	FTP

# Drug_Target_1_Protein_Sequence:
>Bacillolysin precursor
MKRKMKMKLVRFGLAAGLAAQVFFLPYNALASTEHVTWNQQFQTPQFISGDLLKVNGTSP
EELVYQYVEKNENKFKFHENAKDTLQLKEKKNDNLGFTFMRFQQTYKGIPVFGAVVTAHV
KDGTLTALSGTLIPNLDTKGSLKSGKKLSEKQARDIAEKDLVANVTKEVPEYEQGKDTEF
VVYVNGDEASLAYVVNLNFLTPEPGNWLYIIDAVDGKILNKFNQLDAAKPGDVKSITGTS
TVGVGRGVLGDQKNINTTYSTYYYLQDNTRGNGIFTYDAKYRTTLPGSLWADADNQFFAS
YDAPAVDAHYYAGVTYDYYKNVHNRLSYDGNNAAIRSSVHYSQGYNNAFWNGSQMVYGDG
DGQTFIPLSGGIDVVAHELTHAVTDYTAGLIYQNESGAINEAISDIFGTLVEFYANKNPD
WEIGEDVYTPGISGDSLRSMSDPAKYGDPDHYSKRYTGTQDNGGVHINSGIINKAAYLIS
QGGTHYGVSVVGIGRDKLGKIFYRALTQYLTPTSNFSQLRAAAVQSATDLYGSTSQEVAS
VKQAFDAVGVK

# Drug_Target_1_Reaction:
Similar, but not identical, to that of thermolysin

# Drug_Target_1_Signals:
1-31

# Drug_Target_1_Specific_Function:
Extracellular zinc metalloprotease

# Drug_Target_1_SwissProt_ID:
P43133

# Drug_Target_1_SwissProt_Name:
NPRS_GEOSE

# Drug_Target_1_Synonyms:
Bacillolysin precursor
EC 3.4.24.28
Neutral protease

# Drug_Target_1_Theoretical_pI:
6.15

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Cytoplasmic

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X14777

# Drug_Target_2_GenBank_ID_Protein:
4185897

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
ansB

# Drug_Target_2_Gene_Sequence:
>1047 bp
ATGGAAAGATGGTTTAAATCTCTGTTTGTTCTGGTTTTATTTTTTGTTTTTACGGCGAGT
GCGGCAGATAAACTGCCCAATATCGTTATCCTGGCGACCGGCGGTACAATTGCCGGCTCA
GCGGCAACGGGTACCCAAACCACAGGTTACAAGGCTGGCGCGCTTGGCGTGGATACGCTA
ATCAACGCTGTGCCTGAGGTGAAGAAACTGGCTAATGTGAAGGGGGAGCAGTTCTCCAAC
ATGGCCAGCGAAAACATGACCGGTGATGTGGTGCTCAAGCTGAGCCAGCGTGTGAATGAA
CTGCTGGCACGGGATGATGTGGATGGTGTGGTGATCACCCACGGGACCGACACGGTGGAA
GAGTCGGCTTACTTTCTTCATCTGACGGTAAAAAGTGACAAGCCAGTGGTGTTTGTCGCA
GCGATGCGTCCGGCAACGGCCATCAGTGCTGACGGCCCGATGAACCTGCTGGAAGCGGTA
CGCGTGGCGGGTGACAAACAGTCTCGCGGTCGCGGCGTGATGGTGGTGCTTAATGATCGT
ATCGGCTCTGCCCGCTACATCACCAAGACCAACGCCTCTACGCTGGATACGTTCAAGGCG
AATGAAGAAGGCTACCTGGGCGTCATTATTGGTAACCGCATTTACTACCAAAACCGAATC
GACAAGCTGCATACCACCCGGTCTGTGTTCGACGTGCGTGGCCTGACTTCGCTGCCGAAA
GTCGACATTCTTTATGGCTATCAGGATGACCCGGAATATCTGTATGACGCGGCTATCCAG
CATGGCGTAAAAGGTATCGTCTATGCCGGTATGGGCGCAGGTTCAGTGTCCGTTCGCGGT
ATTGCCGGTATGCGCAAGGCGATGGAGAAAGGCGTTGTTGTGATCCGTTCTACCCGCACA
GGCAATGGTATTGTGCCGCCGGATGAAGAGCTGCCAGGTCTGGTTTCTGACTCTCTTAAC
CCGGCACATGCCCGCATTCTGTTGATGCTGGCATTGACTCGCACCAGTGATCCGAAAGTC
ATTCAAGAGTATTTCCATACTTATTGA

# Drug_Target_2_General_Function:
Amino acid transport and metabolism

# Drug_Target_2_General_References:
3026924	Minton NP, Bullman HM, Scawen MD, Atkinson T, Gilbert HJ: Nucleotide sequence of the Erwinia chrysanthemi NCPPB 1066 L-asparaginase gene. Gene. 1986;46(1):25-35.
3194219	Filpula D, Nagle JW, Pulford S, Anderson DM: Sequence of L-asparaginase gene from Erwinia chrysanthemi NCPPB 1125. Nucleic Acids Res. 1988 Nov 11;16(21):10385.
3379033	Tanaka S, Robinson EA, Appella E, Miller M, Ammon HL, Roberts J, Weber IT, Wlodawer A: Structures of amidohydrolases. Amino acid sequence of a glutaminase-asparaginase from Acinetobacter glutaminasificans and preliminary crystallographic data for an asparaginase from Erwinia chrysanthemi. J Biol Chem. 1988 Jun 25;263(18):8583-91.
8348975	Miller M, Rao JK, Wlodawer A, Gribskov MR: A left-handed crossover involved in amidohydrolase catalysis. Crystal structure of Erwinia chrysanthemi L-asparaginase with bound L-aspartate. FEBS Lett. 1993 Aug 16;328(3):275-9.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
2791

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
37576

# Drug_Target_2_Name:
L-asparaginase

# Drug_Target_2_Number_of_Residues:
348

# Drug_Target_2_PDB_ID:
1O7J

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00710	Asparaginase

# Drug_Target_2_Protein_Sequence:
>L-asparaginase precursor
MERWFKSLFVLVLFFVFTASAADKLPNIVILATGGTIAGSAATGTQTTGYKAGALGVDTL
INAVPEVKKLANVKGEQFSNMASENMTGDVVLKLSQRVNELLARDDVDGVVITHGTDTVE
ESAYFLHLTVKSDKPVVFVAAMRPATAISADGPMNLLEAVRVAGDKQSRGRGVMVVLNDR
IGSARYITKTNASTLDTFKANEEGYLGVIIGNRIYYQNRIDKLHTTRSVFDVRGLTSLPK
VDILYGYQDDPEYLYDAAIQHGVKGIVYAGMGAGSVSVRGIAGMRKAMEKGVVVIRSTRT
GNGIVPPDEELPGLVSDSLNPAHARILLMLALTRTSDPKVIQEYFHTY

# Drug_Target_2_Reaction:
L-asparagine + H2O = L-aspartate + NH3

# Drug_Target_2_Signals:
1-21

# Drug_Target_2_Specific_Function:
L-asparagine + H(2)O = L-aspartate + NH(3)

# Drug_Target_2_SwissProt_ID:
P06608

# Drug_Target_2_SwissProt_Name:
ASPG_ERWCH

# Drug_Target_2_Synonyms:
EC 3.5.1.1
L-ASNase
L-asparaginase precursor
L-asparagine amidohydrolase

# Drug_Target_2_Theoretical_pI:
8.62

# Drug_Target_2_Transmembrane_Regions:
None

#END_DRUGCARD DB02655
